April 11, 2025

Alzheimer’s Risk Factors Linked to Cognition Early

Study of U.S. adults aged 24 to 44 finds associations between Alzheimer’s risk markers and cognitive performance decades before typical onset.

Conexiant

April 10, 2025

Diagnosed ADHD Associated with Reduced Lifespan

Adults diagnosed with ADHD in the UK had shorter life expectancy than matched peers

Conexiant

April 10, 2025

Study: LLMs Show Biases in Medical Decision-Making

Large language models recommend different care based on patients' race, housing status, income level, and sexual orientation, potentially amplifying health care disparities if deployed without safeguards, researchers find.

Conexiant

April 10, 2025

Model Predicts Pediatric Seizure Recurrence

Elevated risk scores are significantly associated with an increased likelihood of seizure recurrence, according to a recent study on pediatric epilepsy.

Conexiant

April 10, 2025

Morning Coffee Consumption Linked to Lower Mortality Risk

“Drinking coffee in the morning may be more strongly associated with a lower risk of mortality than drinking coffee later in the day."

Conexiant

April 09, 2025

Oral Microbiome Linked to Chronic Pain in Women

Study finds poor oral health and oral pathobionts associated with pain in migraine, fibromyalgia, and abdominal disorders, suggesting possible treatment avenues.

Conexiant

April 07, 2025

GLP-1, SGLT2 Found to Reduce Alzheimer's Risk

New study finds GLP-1 agonists and SGLT2 inhibitors associated with reduced risk of dementia in type 2 diabetes patients compared to other glucose-lowering medications.

Conexiant

April 07, 2025

Cannabis for Pain: ACP Issues Best Practices

New guidelines from the American College of Physicians address the limited benefits and potential harms of cannabis and cannabinoids for chronic noncancer pain management.

Conexiant

April 04, 2025

First IgG4-RD Treatment Approved

A humanized monoclonal antibody that targets CD19+ B cells is first FDA-approved treatment for immunoglobulin G4–related disease, reducing flare risk and glucocorticoid use in clinical trials.

Conexiant